Insider Transactions in Q4 2023 at Akoya Biosciences, Inc. (AKYA)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 19
2023
|
Brian Mc Kelligon President and CEO |
SELL
Open market or private sale
|
Direct |
7,500
-4.69%
|
$30,000
$4.48 P/Share
|
|
Dec 19
2023
|
Brian Mc Kelligon President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+4.48%
|
$0
$0.3 P/Share
|
|
Dec 12
2023
|
Brian Mc Kelligon President and CEO |
SELL
Open market or private sale
|
Direct |
7,500
-4.69%
|
$30,000
$4.25 P/Share
|
|
Dec 12
2023
|
Brian Mc Kelligon President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+4.48%
|
$0
$0.3 P/Share
|
|
Nov 20
2023
|
Brian Mc Kelligon President and CEO |
SELL
Open market or private sale
|
Direct |
7,500
-4.69%
|
$30,000
$4.39 P/Share
|
|
Nov 20
2023
|
Brian Mc Kelligon President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+4.48%
|
$0
$0.3 P/Share
|
|
Nov 06
2023
|
Jennifer Kamocsay General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+30.77%
|
-
|
|
Nov 06
2023
|
Frederic Pla Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+29.83%
|
-
|